SCHEDULE: Trigran Investments Discloses 4.2% Stake in MiMedx Group

Trigran Investments and its principals have reported a 4.2% beneficial ownership stake in MiMedx Group, Inc. as of December 31, 2025.

Summary

• Trigran Investments, Inc. and five individuals (Douglas T. Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon, and Steven R. Monieson) have jointly filed an Amendment No. 1 to Schedule 13G.
• The filing reports beneficial ownership of MiMedx Group, Inc. common stock, CUSIP 602496101.
• As of December 31, 2025, the reporting group beneficially owns an aggregate of 6,163,384 shares.
• This represents 4.2% of MiMedx Group, Inc.'s outstanding common stock.
• The group holds shared voting power over 5,688,192 shares and shared dispositive power over 6,163,384 shares, with no sole voting or dispositive power.
• The reporting persons disclaim beneficial ownership of the shares except to the extent of their pecuniary interest.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant institutional stake (4.2%) suggests investor confidence, although the filing itself is purely informational regarding ownership.

Positives

• A significant institutional investor group, Trigran Investments, Inc. and its principals, holds a 4.2% stake, indicating a notable level of confidence or interest in MiMedx Group, Inc.

Risks

• The reporting persons disclaim beneficial ownership of the shares except to the extent of their pecuniary interest, which is a standard legal disclaimer but clarifies that their direct control or full beneficial interest might be limited to their economic stake.

Future Outlook

NA

Management Comments

• The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.
• The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing indicates passive beneficial ownership by an institutional investor or group, signifying a notable stake in the company without the intent to control or influence management. This type of filing provides transparency regarding significant shareholder positions, which can be a signal of investor interest in the biotechnology or medical device sector where MiMedx Group operates.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake could be viewed positively, potentially signaling validation of the company's value by sophisticated investors.
• Management: Awareness of a substantial passive investor group may influence strategic considerations, though the filing explicitly states no intent to control.

Key Dates

Keywords

MiMedx Group, Trigran Investments, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Equity Stake, SEC Filing